PN,30601
SC,0001
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax 2   F306A1729350802
OL,3,CClinical trial offers new hope to
OL,4,Cwomen with ovarian cancer
OL,6,FWomen with a type of ovarian cancer
OL,7,Fthat is very difficult to treat have
OL,8,Fshown remarkable results on a clinical
OL,9,Ftrial testing a new combination of
OL,10,Fdrugs.
OL,12,FAlmost a third (31%) of women with low-
OL,13,Fgrade serous ovarian cancer, which
OL,14,Fdoes not respond well to chemotherapy,
OL,15,Fsaw their tumours shrink or stop
OL,16,Fgrowing when taking a combination of
OL,17,Favutometinib and defactinib.
OL,1,W~s1{$~k4{$k7                    G1/7
OL,2,W,.!/  +.!/*%*%R,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,RpppppppppppppppppGsource: itv.com/sport
OL,24,ANext Page BNat SportCNat Radio FWeather
FL,307,300,200,120,000,100
PN,30602
SC,0002
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax 2   F306A1729350802
OL,3,CClinical trial offers new hope to
OL,4,Cwomen with ovarian cancer
OL,6,FThe results in patients who had a
OL,7,Fmutation in a gene called KRAS were
OL,8,Feven more promising, with 44% of
OL,9,Fpatients seeing their tumour shrink.
OL,11,FExperts are so excited by the latest
OL,12,Ffindings that they hope the treatment
OL,13,Fwill change practice globally for this
OL,14,Ftype of cancer, and offer hope to
OL,15,Fwomen with no or few treatment options.
OL,1,W~s1{$~k4{$k7                    G2/7
OL,2,W,.!/  +.!/*%*%R,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,RpppppppppppppppppGsource: itv.com/sport
OL,24,ANext Page BNat SportCNat Radio FWeather
FL,307,300,200,120,000,100
PN,30603
SC,0003
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax 2   F306A1729350802
OL,3,CClinical trial offers new hope to
OL,4,Cwomen with ovarian cancer
OL,6,FThe clinical trial on the drugs is
OL,7,Fbeing led by Professor Susana
OL,8,FBanerjee, consultant medical
OL,9,Foncologist at the Royal Marsden NHS
OL,10,FFoundation Trust and from the
OL,11,FInstitute of Cancer Research, London.
OL,13,FShe said: "These are significant
OL,14,Fresults from the second phase of this
OL,15,Ftrial.
OL,17,F"The toxicities for patients are much
OL,18,Flower, which means side effects are
OL,19,Ffewer than with some conventional
OL,20,Ftreatments.
OL,26,@uD@KOUyD@AOU
OL,1,W~s1{$~k4{$k7                    G3/7
OL,2,W,.!/  +.!/*%*%R,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,RpppppppppppppppppGsource: itv.com/sport
OL,24,ANext Page BNat SportCNat Radio FWeather
FL,307,300,200,120,000,100
PN,30604
SC,0004
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax 2   F306A1729350802
OL,3,CClinical trial offers new hope to
OL,4,Cwomen with ovarian cancer
OL,6,F"The combination of avutometinib and
OL,7,Fdefactinib promises a new standard of
OL,8,Fcare for people with recurrent low-
OL,9,Fgrade serous ovarian cancer.
OL,11,F"We're now looking to recruit patients
OL,12,Ffor our phase three trial and hope
OL,13,Fresults will continue to show better
OL,14,Foutcomes for patients."
OL,16,FThe drugs being used in the trial are
OL,17,Finvestigational and are being
OL,18,Fdeveloped by biotech company Verastem
OL,19,FOncology.
OL,26,@nD@AOUsD@AOUvD@WO]
OL,1,W~s1{$~k4{$k7                    G4/7
OL,2,W,.!/  +.!/*%*%R,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,RpppppppppppppppppGsource: itv.com/sport
OL,24,ANext Page BNat SportCNat Radio FWeather
FL,307,300,200,120,000,100
PN,30605
SC,0005
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax 2   F306A1729350802
OL,3,CClinical trial offers new hope to
OL,4,Cwomen with ovarian cancer
OL,6,FThe new Ramp 201 study results were
OL,7,Fpresented on Thursday at the
OL,8,FInternational Gynaecologic Cancer
OL,9,FSociety's meeting in Dublin.
OL,11,FThey showed that in 115 people with
OL,12,Flow-grade serous ovarian cancer, 31%
OL,13,Fsaw their tumours shrink or stop
OL,14,Fgrowing on the drugs, compared to 10%
OL,15,For under response rate to chemotherapy
OL,16,For hormone therapies.
OL,1,W~s1{$~k4{$k7                    G5/7
OL,2,W,.!/  +.!/*%*%R,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,RpppppppppppppppppGsource: itv.com/sport
OL,24,ANext Page BNat SportCNat Radio FWeather
FL,307,300,200,120,000,100
PN,30606
SC,0006
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax 2   F306A1729350802
OL,3,CClinical trial offers new hope to
OL,4,Cwomen with ovarian cancer
OL,6,FLow grade serous ovarian cancer is a
OL,7,Frare subtype of ovarian cancer, which
OL,8,Fis more likely to affect younger women
OL,9,Fand is more resistant to chemotherapy
OL,10,Fthan other types.
OL,12,FMany people are diagnosed when the
OL,13,Fcancer has spread, and more than 70%
OL,14,Fsee their cancer come back even after
OL,15,Fstandard treatment.
OL,17,FBoth avutometinib and defactinib work
OL,18,Fby blocking signals that encourage
OL,19,Fcancer cells to grow.
OL,1,W~s1{$~k4{$k7                    G6/7
OL,2,W,.!/  +.!/*%*%R,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,RpppppppppppppppppGsource: itv.com/sport
OL,24,ANext Page BNat SportCNat Radio FWeather
FL,307,300,200,120,000,100
PN,30607
SC,0007
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax 2   F306A1729350802
OL,3,CClinical trial offers new hope to
OL,4,Cwomen with ovarian cancer
OL,6,FIn the trial, only 10% of patients
OL,7,Fquit, meaning most could tolerate the
OL,8,Fdrugs and any side-effects.
OL,1,W~s1{$~k4{$k7                    G7/7
OL,2,W,.!/  +.!/*%*%R,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,RpppppppppppppppppGsource: itv.com/sport
OL,24,ANext Page BNat SportCNat Radio FWeather
FL,307,300,200,120,000,100
